Skip to content
2000
Volume 21, Issue 8
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Background

Diabetes Mellitus (DM) is an alarming health concern, affecting approximately 537 million people worldwide. As a leading cause of morbidity and mortality, DM demands a comprehensive understanding of its diverse pathophysiological mechanisms and disease progression.

Methods

This traditional review has consolidated literature on the pathogenesis of hyperglycemia, its progression into complications, and advances in optimal treatment strategies. The literature in the last two decades has been reviewed using several keywords, including “diabetes,” “diabetes-associated complications”, “novel therapeutic interventions for diabetes-associated diseases”, “phyto-extracts as antidiabetic drugs”, . in prominent databases, such as PubMed, Scopus, Google Scholar, Web of Science, and ClinicalTrials.gov.

Results

We have discussed macrovascular and microvascular complications, such as atherosclerosis, cardiovascular disease, Peripheral Arterial Disease (PAD), stroke, diabetic nephropathy, retinopathy, and neuropathy, as well as various pharmacological and non-pharmacological interventions that are currently available for the management of DM. We have also focused on the potential of natural products in targeting molecular mechanisms involved in carbohydrate metabolism, insulin production, repair of pancreatic cells, and reduction of oxidative stress, thereby contributing to their antidiabetic activity. Additionally, novel therapeutic approaches, like genetic, stem cell, and immunomodulatory therapies, have been explored. We have also discussed the benefits and limitations of each intervention, emerging research and technologies, and precision medicine interventions.

Conclusion

This review has emphasized the need for an improved understanding of these advancements, which is essential to enhance clinicians' ability to identify the most effective therapeutic interventions.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998291870240408043837
2024-05-03
2025-12-08

  • From This Site

    /content/journals/cdr/10.2174/0115733998291870240408043837
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Edition, I., International Diabetes Federation. IDF Diabetes Atlas.8th edBrussels, BelgiumInternational Diabetes Federation2017
     [Google Scholar]
  2. OngK.L. StaffordL.K. McLaughlinS.A. BoykoE.J. VollsetS.E. SmithA.E. DaltonB.E. DupreyJ. CruzJ.A. HaginsH. LindstedtP.A. AaliA. AbateY.H. AbateM.D. AbbasianM. Abbasi-KangevariZ. Abbasi-KangevariM. Abd ElHafeezS. Abd-RabuR. AbdulahD.M. AbdullahA.Y.M. AbediV. AbidiH. AboagyeR.G. AbolhassaniH. Abu-GharbiehE. Abu-ZaidA. AdaneT.D. AdaneD.E. AddoI.Y. AdegboyeO.A. AdekanmbiV. AdepojuA.V. AdnaniQ.E.S. AfolabiR.F. AgarwalG. AghdamZ.B. Agudelo-BoteroM. Aguilera ArriagadaC.E. Agyemang-DuahW. AhinkorahB.O. AhmadD. AhmadR. AhmadS. AhmadA. AhmadiA. AhmadiK. AhmedA. AhmedA. AhmedL.A. AhmedS.A. AjamiM. AkinyemiR.O. Al HamadH. Al HasanS.M. AL-AhdalT.M.A. AlalwanT.A. Al-AlyZ. AlBatainehM.T. Alcalde-RabanalJ.E. AlemiS. AliH. AliniaT. AljunidS.M. AlmustanyirS. Al-RaddadiR.M. Alvis-GuzmanN. AmareF. AmeyawE.K. AmiriS. AmusaG.A. AndreiC.L. AnjanaR.M. AnsarA. AnsariG. Ansari-MoghaddamA. AnyasodorA.E. ArablooJ. AravkinA.Y. AredaD. ArifinH. ArkewM. ArmocidaB. ÄrnlövJ. ArtamonovA.A. ArulappanJ. ArulebaR.T. ArumugamA. AryanZ. AsemuM.T. Asghari-JafarabadiM. AskariE. AsmelashD. Astell-BurtT. AtharM. AthariS.S. AtoutM.M.W. Avila-BurgosL. AwaisuA. AzadnajafabadS. BD.B. BabamohamadiH. BadarM. BadawiA. BadiyeA.D. BaghcheghiN. BagheriN. BagheriehS. BahS. BahadoryS. BaiR. BaigA.A. BaltatuO.C. BaradaranH.R. BarchittaM. BardhanM. BarengoN.C. BärnighausenT.W. BaroneM.T.U. Barone-AdesiF. BarrowA. BashiriH. BasiruA. BasuS. BasuS. BatihaA-M.M. BatraK. BayihM.T. BayileyegnN.S. BehnoushA.H. BekeleA.B. BeleteM.A. BelgaumiU.I. BeloL. BennettD.A. BensenorI.M. BerheK. BerhieA.Y. BhaskarS. BhatA.N. BhattiJ.S. BikbovB. BilalF. BintoroB.S. BitarafS. BitraV.R. Bjegovic-MikanovicV. BodolicaV. BoloorA. BrauerM. Brazo-SayaveraJ. BrennerH. ButtZ.A. CalinaD. CamposL.A. Campos-NonatoI.R. CaoY. CaoC. CarJ. CarvalhoM. Castañeda-OrjuelaC.A. Catalá-LópezF. CerinE. ChadwickJ. ChandrasekarE.K. ChanieG.S. CharanJ. ChattuV.K. ChauhanK. CheemaH.A. Chekol AbebeE. ChenS. CherbuinN. ChichagiF. ChidambaramS.B. ChoW.C.S. ChoudhariS.G. ChowdhuryR. ChowdhuryE.K. ChuD-T. ChukwuI.S. ChungS-C. CoberlyK. ColumbusA. ContrerasD. CousinE. CriquiM.H. Cruz-MartinsN. CuschieriS. DaboB. DadrasO. DaiX. DamascenoA.A.M. DandonaR. DandonaL. DasS. DascaluA.M. DashN.R. DashtiM. Dávila-CervantesC.A. De la Cruz-GóngoraV. DebeleG.R. DelpasandK. DemisseF.W. DemissieG.D. DengX. Denova-GutiérrezE. DeoS.V. DerviševićE. DesaiH.D. DesaleA.T. DessieA.M. DestaF. DewanS.M.R. DeyS. DhamaK. DhimalM. DiaoN. DiazD. DinuM. DiressM. DjalaliniaS. DoanL.P. DongarwarD. dos Santos FigueiredoF.W. DuncanB.B. DuttaS. DziedzicA.M. EdinurH.A. EkholuenetaleM. EkundayoT.C. ElgendyI.Y. ElhadiM. El-HuneidiW. ElmeligyO.A.A. ElmonemM.A. EndeshawD. EsayasH.L. EshetuH.B. EtaeeF. FadhilI. FagbamigbeA.F. FahimA. FalahiS. FarisM.A.I.E.M. FarrokhpourH. FarzadfarF. FatehizadehA. FazliG. FengX. FeredeT.Y. FischerF. FloodD. ForouhariA. ForoumadiR. Foroutan KoudehiM. GaidhaneA.M. GaihreS. GaipovA. GalaliY. GanesanB. Garcia-GordilloM.A. GautamR.K. GebrehiwotM. GebrekidanK.G. GebremeskelT.G. GetacherL. GhadirianF. GhamariS-H. Ghasemi NourM. GhassemiF. GolechhaM. GoleijP. GolinelliD. GopalaniS.V. GuadieH.A. GuanS-Y. GudayuT.W. GuimarãesR.A. GuledR.A. GuptaR. GuptaK. GuptaV.B. GuptaV.K. GyawaliB. HaddadiR. HadiN.R. HaileT.G. HajibeygiR. Haj-MirzaianA. HalwaniR. HamidiS. HankeyG.J. HannanM.A. HaqueS. HarandiH. HarliantoN.I. HasanS.M.M. HasanS.S. HasaniH. HassanipourS. HassenM.B. HauboldJ. HayatK. HeidariG. HeidariM. HessamiK. HiraikeY. HollaR. HossainS. HossainM.S. HosseiniM-S. HosseinzadehM. HosseinzadehH. HuangJ. HudaM.N. HussainS. HuynhH-H. HwangB-F. IbitoyeS.E. IkedaN. IlicI.M. IlicM.D. InbarajL.R. IqbalA. IslamS.M.S. IslamR.M. IsmailN.E. IsoH. IsolaG. ItumallaR. IwagamiM. IwuC.C.D. IyamuI.O. IyasuA.N. JacobL. JafarzadehA. JahramiH. JainR. JajaC. JamalpoorZ. JamshidiE. JanakiramanB. JayannaK. JayapalS.K. JayaramS. JayawardenaR. JebaiR. JeongW. JinY. JokarM. JonasJ.B. JosephN. JosephA. JoshuaC.E. JoukarF. JozwiakJ.J. KaambwaB. KabirA. KabthymerR.H. KadashettiV. KaheF. KalhorR. KandelH. KaranthS.D. KarayeI.M. KarkhahS. KatotoP.D.M.C. KaurN. KazemianS. KebedeS.A. KhaderY.S. KhajuriaH. KhalajiA. KhanM.A.B. KhanM. KhanA. KhanalS. KhatatbehM.M. KhaterA.M. KhateriS. khorashadizadehF. KhubchandaniJ. KibretB.G. KimM.S. KimokotiR.W. KisaA. KivimäkiM. KolahiA-A. KomakiS. KompaniF. KoohestaniH.R. KorzhO. KostevK. KothariN. KoyanagiA. KrishanK. KrishnamoorthyY. Kuate DefoB. KuddusM. KuddusM.A. KumarR. KumarH. KunduS. KurniasariM.D. KuttikkattuA. La VecchiaC. LallukkaT. LarijaniB. LarssonA.O. LatiefK. LawalB.K. LeT.T.T. LeT.T.B. LeeS.W.H. LeeM. LeeW-C. LeeP.H. LeeS. LeeS.W. LegesseS.M. LenziJ. LiY. LiM-C. LimS.S. LimL-L. LiuX. LiuC. LoC-H. LopesG. LorkowskiS. LozanoR. LucchettiG. MaghazachiA.A. MahashaP.W. MahjoubS. MahmoudM.A. MahmoudiR. MahmoudimaneshM. MaiA.T. MajeedA. Majma SanayeP. MakrisK.C. MalhotraK. MalikA.A. MalikI. MallhiT.H. MaltaD.C. MamunA.A. MansouriB. MaratebH.R. MardiP. MartiniS. MartorellM. MarzoR.R. MasoudiR. MasoudiS. MathewsE. MaugeriA. MazzagliaG. MekonnenT. MeshkatM. MestrovicT. Miao JonassonJ. MiazgowskiT. MichalekI.M. MinhL.H.N. MiniG.K. MirandaJ.J. MirfakhraieR. MirrakhimovE.M. Mirza-Aghazadeh-AttariM. MisganawA. MisginaK.H. MishraM. MoazenB. MohamedN.S. MohammadiE. MohammadiM. Mohammadian-HafshejaniA. MohammadshahiM. MohseniA. Mojiri-forushaniH. MokdadA.H. MomtazmaneshS. MonastaL. MoniruzzamanM. MonsU. MontazeriF. Moodi GhalibafA.A. MoradiY. MoradiM. Moradi SarabiM. MorovatdarN. MorrisonS.D. MorzeJ. MossialosE. MostafaviE. MuellerU.O. MulitaF. MulitaA. Murillo-ZamoraE. MusaK.I. MwitaJ.C. NagarajuS.P. NaghaviM. NainuF. NairT.S. NajmuldeenH.H.R. NangiaV. NargusS. NaserA.Y. NassereldineH. NattoZ.S. NaumanJ. NayakB.P. NdejjoR. NegashH. NegoiR.I. NguyenH.T.H. NguyenD.H. NguyenP.T. NguyenV.T. NguyenH.Q. NiaziR.K. NigatuY.T. NingrumD.N.A. NizamM.A. NnyanziL.A. NoreenM. NoubiapJ.J. NzoputamO.J. NzoputamC.I. OanceaB. OdogwuN.M. OdukoyaO.O. OjhaV.A. Okati-AliabadH. OkekunleA.P. OkonjiO.C. OkwuteP.G. OlufadewaI.I. OnwujekweO.E. OrdakM. OrtizA. OsuagwuU.L. OulhajA. OwolabiM.O. Padron-MonederoA. PadubidriJ.R. PalladinoR. PanagiotakosD. Panda-JonasS. PandeyA. PandeyA. Pandi-PerumalS.R. Pantea StoianA.M. PardhanS. ParekhT. ParekhU. PasovicM. PatelJ. PatelJ.R. PaudelU. PepitoV.C.F. PereiraM. PericoN. PernaS. PetcuI-R. Petermann-RochaF.E. PodderV. PostmaM.J. PouraliG. PourtaheriN. PratesE.J.S. QadirM.M.F. QatteaI. RaeeP. RafiqueI. RahimiM. RahimifardM. Rahimi-MovagharV. RahmanM.O. RahmanM.A. RahmanM.H.U. RahmanM. RahmanM.M. RahmaniM. RahmaniS. RahmanianV. RahmawatyS. RahnavardN. RajbhandariB. RamP. RamazanuS. RanaJ. RancicN. RanjhaM.M.A.N. RaoC.R. RapakaD. RasaliD.P. RashediS. RashediV. RashidA.M. RashidiM-M. RatanZ.A. RawafS. RawalL. RedwanE.M.M. RemuzziG. RengasamyK.R.R. RenzahoA.M.N. ReyesL.F. RezaeiN. RezaeiN. RezaeianM. RezazadehH. RiahiS.M. RiasY.A. RiazM. RibeiroD. RodriguesM. RodriguezJ.A.B. RoeverL. RohloffP. RoshandelG. RoustazadehA. RwegereraG.M. SaadA.M.A. Saber-AyadM.M. SabourS. SabzmakanL. SaddikB. SadeghiE. SaeedU. Saeedi MoghaddamS. SafiS. SafiS.Z. SaghazadehA. Saheb Sharif-AskariN. Saheb Sharif-AskariF. SahebkarA. SahooS.S. SahooH. Saif-Ur-RahmanK.M. SajidM.R. SalahiS. SalahiS. SalehM.A. SalehiM.A. SalomonJ.A. SanabriaJ. SanjeevR.K. SanmarchiF. Santric-MilicevicM.M. SarasmitaM.A. SargaziS. SathianB. SathishT. SawhneyM. SchlaichM.P. SchmidtM.I. SchuermansA. SeiduA-A. Senthil KumarN. SepanlouS.G. SethiY. SeylaniA. ShabanyM. ShafaghatT. ShafeghatM. ShafieM. ShahN.S. ShahidS. ShaikhM.A. ShanawazM. ShannawazM. SharfaeiS. ShashamoB.B. ShiriR. ShittuA. ShivakumarK.M. ShivalliS. ShobeiriP. ShokriF. ShuvalK. SibhatM.M. SilvaL.M.L.R. SimpsonC.R. SinghJ.A. SinghP. SinghS. SirajM.S. SkryabinaA.A. SohagA.A.M. SoleimaniH. SolikhahS. Soltani-ZangbarM.S. SomayajiR. SorensenR.J.D. StarodubovaA.V. SujataS. SulemanM. SunJ. SundströmJ. Tabarés-SeisdedosR. TabatabaeiS.M. TabatabaeizadehS-A. TabishM. TaheriM. TaheriE. TakiE. TamuziJ.J.L.L. TanK-K. TatN.Y. TayeB.T. TemesgenW.A. TemsahM-H. TeslerR. ThangarajuP. ThankappanK.R. ThapaR. TharwatS. ThomasN. TicoaluJ.H.V. TiyuriA. TonelliM. Tovani-PaloneM.R. TricoD. TrihandiniI. TripathyJ.P. TromansS.J. TsegayG.M. TualekaA.R. TufaD.G. TyrovolasS. UllahS. UpadhyayE. VahabiS.M. VaithinathanA.G. ValizadehR. van DaalenK.R. VartP. VarthyaS.B. VasankariT.J. VaziriS. VermaM. VerrasG-I. VoD.C. WagayeB. WaheedY. WangZ. WangY. WangC. WangF. WassieG.T. WeiM.Y.W. WeldemariamA.H. WestermanR. WickramasingheN.D. WuY.F. WulandariR.D.W.I. XiaJ. XiaoH. XuS. XuX. YadaD.Y. YangL. YatsuyaH. YesiltepeM. YiS. YohannisH.K. YonemotoN. YouY. ZamanS.B. ZamoraN. ZareI. ZareaK. ZarrintanA. ZastrozhinM.S. ZeruN.G. ZhangZ-J. ZhongC. ZhouJ. ZielińskaM. ZikargY.T. ZodpeyS. ZoladlM. ZouZ. ZumlaA. ZunigaY.M.H. MaglianoD.J. MurrayC.J.L. HayS.I. VosT. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet20234021039720323410.1016/S0140‑6736(23)01301‑637356446
     [Google Scholar]
  3. AssociationA.D. 1. Improving care and promoting health in populations: Standards of medical care in diabetes—2021.Diabetes Care202144Suppl. 1S7S1410.2337/dc21‑S00133298412
     [Google Scholar]
  4. NathanD.M. GroupD.E.R. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview.Diabetes Care201437191610.2337/dc13‑211224356592
     [Google Scholar]
  5. YamadaY. KatagiriH. HamamotoY. DeenadayalanS. NavarriaA. NishijimaK. SeinoY. FukushimaY. HamamotoY. HisatomiA. IdeY. InoueS. KawadaT. KimH. KiyosueA. MatobaK. MatsuokaO. NishimuraH. NoguchiM. OsonoiT. SawadaS. ShibasakiY. ShinK. YamadaY. Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): A 52-week, phase 2/3a, randomised, controlled trial.Lancet Diabetes Endocrinol.20208537739110.1016/S2213‑8587(20)30075‑932333875
     [Google Scholar]
  6. PrasadR. GroopL. Genetics of type 2 diabetes-pitfalls and possibilities.Genes2015618712310.3390/genes601008725774817
     [Google Scholar]
  7. Gómez-HernándezA. de las HerasN. López-PastorA.R. García-GómezG. Infante-MenéndezJ. González-LópezP. González-IllanesT. LaheraV. BenitoM. EscribanoÓ. Severe hepatic insulin resistance induces vascular dysfunction: Improvement by liver-specific insulin receptor isoform a gene therapy in a murine diabetic model.Cells2021108203510.3390/cells1008203534440804
     [Google Scholar]
  8. SchernthanerG. Schernthaner-ReiterM.H. SchernthanerG.H. EMPA-REG and other cardiovascular outcome trials of glucose-lowering agents: implications for future treatment strategies in type 2 diabetes mellitus.Clin. Ther.20163861288129810.1016/j.clinthera.2016.04.03727210264
     [Google Scholar]
  9. ChewM. TanN.Y.Q. LamoureuxE. ChengC.Y. WongT.Y. SabanayagamC. The associations of objectively measured sleep duration and sleep disturbances with diabetic retinopathy.Diabetes Res. Clin. Pract.202015910796710.1016/j.diabres.2019.10796731805348
     [Google Scholar]
  10. PetersT.M. HolmesM.V. RichardsJ.B. PalmerT. ForgettaV. LindgrenC.M. AsselbergsF.W. NelsonC.P. SamaniN.J. McCarthyM.I. MahajanA. Davey SmithG. WoodwardM. O’KeeffeL.M. PetersS.A.E. Sex differences in the risk of coronary heart disease associated with type 2 diabetes: A Mendelian randomization analysis.Diabetes Care202144255656210.2337/dc20‑113733277303
     [Google Scholar]
  11. ForbesJ.M. CooperM.E. Mechanisms of diabetic complications.Physiol. Rev.201393113718810.1152/physrev.00045.201123303908
     [Google Scholar]
  12. CerielloA. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus.Diabetes Metab. Res. Rev.200016212513210.1002/(SICI)1520‑7560(200003/04)16:2<125::AID‑DMRR90>3.0.CO;2‑410751752
     [Google Scholar]
  13. AronowW.S. AhnC. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus.Chest1999115386786810.1378/chest.115.3.86710084505
     [Google Scholar]
  14. ShantikumarS. AjjanR. PorterK.E. ScottD.J.A. Diabetes and the abdominal aortic aneurysm.Eur. J. Vasc. Endovasc. Surg.201039220020710.1016/j.ejvs.2009.10.01419948418
     [Google Scholar]
  15. DhingraR. VasanR.S. Diabetes and the risk of heart failure.Heart Fail. Clin.20128112513310.1016/j.hfc.2011.08.00822108732
     [Google Scholar]
  16. AssociationA.D. Peripheral arterial disease in people with diabetes.Diabetes Care200326123333334110.2337/diacare.26.12.333314633825
     [Google Scholar]
  17. GiannopoulosS. ArmstrongE.J. Diabetes mellitus: An important risk factor for peripheral vascular disease.Expert Rev. Cardiovasc. Ther.202018313113710.1080/14779072.2020.173656232129693
     [Google Scholar]
  18. BrandF.N. AbbottR.D. KannelW.B. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.Diabetes198938450450910.2337/diab.38.4.5042925008
     [Google Scholar]
  19. SharpA. ClarkJ. Diabetes and its impact on wound healing.Nurs Stand. 201125454147
     [Google Scholar]
  20. DillinghamT.R. PezzinL.E. ShoreA.D. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations.Arch. Phys. Med. Rehabil.200586348048610.1016/j.apmr.2004.06.07215759232
     [Google Scholar]
  21. LeibsonC.L. RansomJ.E. OlsonW. ZimmermanB.R. O’FallonW.M. PalumboP.J. Peripheral arterial disease, diabetes, and mortality.Diabetes Care200427122843284910.2337/diacare.27.12.284315562195
     [Google Scholar]
  22. WymanJ.F. BurgioK.L. NewmanD.K. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.Int. J. Clin. Pract.20096381177119110.1111/j.1742‑1241.2009.02078.x19575724
     [Google Scholar]
  23. PetersS.A.E. HuxleyR.R. WoodwardM. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes.Lancet201438399331973198010.1016/S0140‑6736(14)60040‑424613026
     [Google Scholar]
  24. WinerN. SowersJ.R. Epidemiology of diabetes.J. Clin. Pharmacol.200444439740510.1177/009127000426301715051748
     [Google Scholar]
  25. WooD. HaverbuschM. SekarP. KisselaB. KhouryJ. SchneiderA. KleindorferD. SzaflarskiJ. PancioliA. JauchE. MoomawC. SauerbeckL. GebelJ. BroderickJ. Effect of untreated hypertension on hemorrhagic stroke.Stroke20043571703170810.1161/01.STR.0000130855.70683.c815155969
     [Google Scholar]
  26. ZeemanG.G. Obstetric critical care: A blueprint for improved outcomes.Crit. Care Med.2006349Suppl.S208S21410.1097/01.CCM.0000231884.99763.6916917425
     [Google Scholar]
  27. SalomãoS.R. MitsuhiroM.R.K.H. BelfortR.Jr Visual impairment and blindness: An overview of prevalence and causes in Brazil.An. Acad. Bras. Cienc.200981353954910.1590/S0001‑3765200900030001719722022
     [Google Scholar]
  28. SilviaR.C. VijayalakshmiR. Detection of non-proliferative diabetic retinopathy in fundus images of the human retina.2013 International Conference on Information Communication and Embedded Systems (ICICES), Chennai, India, 21-22 February 2013, pp. 978-983.10.1109/ICICES.2013.6508242
     [Google Scholar]
  29. GrauslundJ. Diabetic retinopathy screening in the emerging era of artificial intelligence.Diabetologia20226591415142310.1007/s00125‑022‑05727‑035639120
     [Google Scholar]
  30. GündüzK. BakriS.J. Management of proliferative diabetic retinopathy.Compr. Ophthalmol. Update20078524525618201511
     [Google Scholar]
  31. TangJ. LiuH. SunM. ZhangX. ChuH. LiQ. ProkoschV. CuiH. Aqueous humor cytokine response in the contralateral eye after first-eye cataract surgery in patients with primary angle-closure glaucoma, high myopia or type 2 diabetes mellitus.Front. Biosci.202227722210.31083/j.fbl270722235866408
     [Google Scholar]
  32. KellyK.J. DominguezJ.H. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure.Am. J. Nephrol.201032546947510.1159/00032074920956853
     [Google Scholar]
  33. KashiharaN. HarunaY. KondetiV.K. KanwarY.S. Oxidative stress in diabetic nephropathy.Curr. Med. Chem.201017344256426910.2174/09298671079334858120939814
     [Google Scholar]
  34. ByunS.H. MaS.H. JunJ.K. JungK.W. ParkB. Screening for diabetic retinopathy and nephropathy in patients with diabetes: A nationwide survey in Korea.PLoS One201385e6299110.1371/journal.pone.006299123667557
     [Google Scholar]
  35. AslamA. SinghJ. RajbhandariS. Pathogenesis of painful diabetic neuropathy. Pain Res Treat.2014201441204110.1155/2014/412041
     [Google Scholar]
  36. GylfadottirS.S. WeeracharoenkulD. AndersenS.T. NiruthisardS. SuwanwalaikornS. JensenT.S. Painful and non‐painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues.J. Diabetes Investig.20191051148115710.1111/jdi.1310531222961
     [Google Scholar]
  37. LeinningerG.M. VincentA.M. FeldmanE.L. The role of growth factors in diabetic peripheral neuropathy.J. Peripher. Nerv. Syst.200491265310.1111/j.1085‑9489.2004.09105.x14871451
     [Google Scholar]
  38. VinikA.I. MaserR.E. MitchellB.D. FreemanR. Diabetic autonomic neuropathy.Diabetes Care20032651553157910.2337/diacare.26.5.155312716821
     [Google Scholar]
  39. JeffcoateW.J. GameF. CavanaghP.R. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.Lancet200536695022058206110.1016/S0140‑6736(05)67029‑816338454
     [Google Scholar]
  40. ArmstrongD.G. LipskyB.A. Diabetic foot infections: Stepwise medical and surgical management.Int. Wound J.20041212313210.1111/j.1742‑4801.2004.00035.x16722884
     [Google Scholar]
  41. Brown AF. Mangione CM. California healthcare foundation/american geriatrics society panel on improving care for elders with diabetes. Guidelines for improving the care of the older person with diabetes mellitus.J. Am. Geriatr. Soc.2003515s26528010.1046/j.1532‑5415.51.5s.1.x
     [Google Scholar]
  42. LaffelL. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes.Diabetes Metab. Res. Rev.199915641242610.1002/(SICI)1520‑7560(199911/12)15:6<412::AID‑DMRR72>3.0.CO;2‑810634967
     [Google Scholar]
  43. BarskiL. EshkoliT. BrandstaetterE. JotkowitzA. Euglycemic diabetic ketoacidosis.Eur. J. Intern. Med.20196391410.1016/j.ejim.2019.03.01430910328
     [Google Scholar]
  44. StonerG.D. Hyperosmolar hyperglycemic state.Am. Fam. Physician20057191723173015887451
     [Google Scholar]
  45. LinE.H.B. RutterC.M. KatonW. HeckbertS.R. CiechanowskiP. OliverM.M. LudmanE.J. YoungB.A. WilliamsL.H. McCullochD.K. Von KorffM. Depression and advanced complications of diabetes: A prospective cohort study.Diabetes Care201033226426910.2337/dc09‑106819933989
     [Google Scholar]
  46. JiaG. Whaley-ConnellA. SowersJ.R. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease.Diabetologia2018611212810.1007/s00125‑017‑4390‑428776083
     [Google Scholar]
  47. ChawlaR. ChawlaA. JaggiS. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?Indian J. Endocrinol. Metab.201620454655110.4103/2230‑8210.18348027366724
     [Google Scholar]
  48. VolpeC.M.O. Villar-DelfinoP.H. dos AnjosP.M.F. Nogueira-MachadoJ.A. Cellular death, reactive oxygen species (ROS) and diabetic complications.Cell Death Dis.20189211910.1038/s41419‑017‑0135‑z29371661
     [Google Scholar]
  49. MarrifH.I. Al-SunousiS.I. Pancreatic β cell mass death.Front. Pharmacol.201678310.3389/fphar.2016.0008327092078
     [Google Scholar]
  50. BalabanR.S. NemotoS. FinkelT. Mitochondria, oxidants, and aging.cell2005120448349510.1016/j.cell.2005.02.001
     [Google Scholar]
  51. Marín-RoyoG. RodríguezC. PapeA.L. Jurado-LópezR. LuacesM. AntequeraA. Martínez-GonzalezJ. Souza-NetoF.V. NietoM.L. Martínez-MartínezE. CachofeiroV. The role of mitochondrial oxidative stress in the metabolic alterations in diet‐induced obesity in rats.FASEB J.20193311120601207210.1096/fj.201900347RR31370681
     [Google Scholar]
  52. ForbesJ.M. ThorburnD.R. Mitochondrial dysfunction in diabetic kidney disease.Nat. Rev. Nephrol.201814529131210.1038/nrneph.2018.929456246
     [Google Scholar]
  53. FengS. Levels of inflammatory cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in aqueous humour of patients with diabetic retinopathy.J Diabetes Res.201820188546423
     [Google Scholar]
  54. PatelS. SantaniD. Role of NF-κB in the pathogenesis of diabetes and its associated complications.Pharmacol. Rep.200961459560310.1016/S1734‑1140(09)70111‑219815941
     [Google Scholar]
  55. DingS. XuS. MaY. LiuG. JangH. FangJ. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes.Biomolecules201991285010.3390/biom912085031835423
     [Google Scholar]
  56. GreenC.L. LammingD.W. FontanaL. Molecular mechanisms of dietary restriction promoting health and longevity.Nat. Rev. Mol. Cell Biol.2022231567310.1038/s41580‑021‑00411‑434518687
     [Google Scholar]
  57. EricksonJ.R. PereiraL. WangL. HanG. FergusonA. DaoK. CopelandR.J. DespaF. HartG.W. RipplingerC.M. BersD.M. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.Nature2013502747137237610.1038/nature1253724077098
     [Google Scholar]
  58. TangS.C.W. YiuW.H. Innate immunity in diabetic kidney disease.Nat. Rev. Nephrol.202016420622210.1038/s41581‑019‑0234‑431942046
     [Google Scholar]
  59. BeltramoE. PortaM. Pericyte loss in diabetic retinopathy: Mechanisms and consequences.Curr. Med. Chem.201320263218322510.2174/0929867311320999002223745544
     [Google Scholar]
  60. MenegazzoL. AlbieroM. AvogaroA. FadiniG.P. Endothelial progenitor cells in diabetes mellitus.Biofactors201238319420210.1002/biof.101622488933
     [Google Scholar]
  61. DoghishA.S. BassyouniA.A. MahfouzM.H. Abd El-AzizH.G. ZakariaR.Y. Plasma endoglin in Type2 diabetic patients with nephropathy.Diabetes Metab. Syndr.201913176476810.1016/j.dsx.2018.11.05830641803
     [Google Scholar]
  62. JerumsG. PanagiotopoulosS. PremaratneE. MacIsaacR.J. Integrating albuminuria and GFR in the assessment of diabetic nephropathy.Nat. Rev. Nephrol.20095739740610.1038/nrneph.2009.9119556994
     [Google Scholar]
  63. Pulakazhi VenuV.K. El-DalyM. SaifeddineM. HirotaS.A. DingH. TriggleC.R. HollenbergM.D. Minimizing hyperglycemia-induced vascular endothelial dysfunction by inhibiting endothelial sodium-glucose cotransporter 2 and attenuating oxidative stress: Implications for treating individuals with type 2 diabetes.Can. J. Diabetes201943751051410.1016/j.jcjd.2019.01.00530930073
     [Google Scholar]
  64. BaiB. YangY. WangQ. LiM. TianC. LiuY. AungL.H.H. LiP. YuT. ChuX. NLRP3 inflammasome in endothelial dysfunction.Cell Death Dis.202011977610.1038/s41419‑020‑02985‑x32948742
     [Google Scholar]
  65. LuoE.F. LiH.X. QinY.H. QiaoY. YanG.L. YaoY.Y. LiL.Q. HouJ.T. TangC.C. WangD. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction.World J. Diabetes202112212413710.4239/wjd.v12.i2.12433594332
     [Google Scholar]
  66. De RosaS. ArcidiaconoB. ChiefariE. BrunettiA. IndolfiC. FotiD.P. Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links.Front. Endocrinol.20189210.3389/fendo.2018.0000229387042
     [Google Scholar]
  67. HoC. LeeP.H. HsuY.C. HuangY-T. WangF-S. LinC.L. Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis.Am. J. Med. Sci.2012344537438210.1097/MAJ.0b013e31824369c522270399
     [Google Scholar]
  68. XiaoL. A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy.Biomed Res Int20132013987064
     [Google Scholar]
  69. AgarawalK. Anant KulkarniY. WairkarS. Nanoformulations of flavonoids for diabetes and microvascular diabetic complications.Drug Deliv. Transl. Res.2023131183610.1007/s13346‑022‑01174‑x35637334
     [Google Scholar]
  70. GoldneyJ. SargeantJ.A. DaviesM.J. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.Diabetologia202366101832184510.1007/s00125‑023‑05988‑337597048
     [Google Scholar]
  71. XuQ. WangL. SansgiryS.S. A systematic literature review of predicting diabetic retinopathy, nephropathy and neuropathy in patients with type 1 diabetes using machine learning.J. Med. Artif. Intell.20203610.21037/jmai.2019.10.04
     [Google Scholar]
  72. FeldmanE.L. CallaghanB.C. Pop-BusuiR. ZochodneD.W. WrightD.E. BennettD.L. BrilV. RussellJ.W. ViswanathanV. Diabetic neuropathy.Nat. Rev. Dis. Primers2019514110.1038/s41572‑019‑0092‑131197153
     [Google Scholar]
  73. AzmiS. ElHaddK.T. NelsonA. ChapmanA. BowlingF.L. PerumbalathA. LimJ. MarshallA. MalikR.A. AlamU. Pregabalin in the management of painful diabetic neuropathy: A narrative review.Diabetes Ther.2019101355610.1007/s13300‑018‑0550‑x30565054
     [Google Scholar]
  74. PathanH. WilliamsJ. Basic opioid pharmacology: An update.Br. J. Pain201261111610.1177/204946371243849326516461
     [Google Scholar]
  75. WernickeJ.F. PritchettY.L. D’SouzaD.N. WaningerA. TranP. IyengarS. RaskinJ. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.Neurology20066781411142010.1212/01.wnl.0000240225.04000.1a17060567
     [Google Scholar]
  76. DludlaP.V. NkambuleB.B. CirilliI. MarcheggianiF. MabhidaS.E. ZiqubuK. NtamoY. JackB. NyambuyaT.M. HanserS. Mazibuko-MbejeS.E. Capsaicin, its clinical significance in patients with painful diabetic neuropathy.Biomed. Pharmacother.202215311343910.1016/j.biopha.2022.11343936076554
     [Google Scholar]
  77. GuptaM. KnezevicN.N. Abd-ElsayedA. RayM. PatelK. ChowdhuryB. Treatment of painful diabetic neuropathy—a narrative review of pharmacological and interventional approaches.Biomedicines20219557310.3390/biomedicines905057334069494
     [Google Scholar]
  78. MansourS.E. BrowningD.J. WongK. FlynnH.W.Jr BhavsarA.R. The evolving treatment of diabetic retinopathy.Clin. Ophthalmol.20201465367810.2147/OPTH.S23663732184554
     [Google Scholar]
  79. KorobelnikJ.F. DoD.V. Schmidt-ErfurthU. BoyerD.S. HolzF.G. HeierJ.S. MidenaE. KaiserP.K. TerasakiH. MarcusD.M. NguyenQ.D. JaffeG.J. SlakterJ.S. SimaderC. SooY. SchmelterT. YancopoulosG.D. StahlN. VittiR. BerlinerA.J. ZeitzO. MetzigC. BrownD.M. Intravitreal aflibercept for diabetic macular edema.Ophthalmology2014121112247225410.1016/j.ophtha.2014.05.00625012934
     [Google Scholar]
  80. KaurS. YangzesS. SinghS. SachdevN. Efficacy and safety of topical difluprednate in persistent diabetic macular edema.Int. Ophthalmol.201636333534010.1007/s10792‑015‑0121‑326296375
     [Google Scholar]
  81. KimS.J. SchoenbergerS.D. ThorneJ.E. EhlersJ.P. YehS. BakriS.J. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: A report by the American Academy of Ophthalmology.Ophthalmology2015122112159216810.1016/j.ophtha.2015.05.01426123091
     [Google Scholar]
  82. MauerM. ZinmanB. GardinerR. SuissaS. SinaikoA. StrandT. DrummondK. DonnellyS. GoodyerP. GublerM.C. KleinR. Renal and retinal effects of enalapril and losartan in type 1 diabetes.N. Engl. J. Med.20093611405110.1056/NEJMoa080840019571282
     [Google Scholar]
  83. Feldman-BillardS. LargerÉ. MassinP. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes.Diabetes Metab.201844141410.1016/j.diabet.2017.10.01429217386
     [Google Scholar]
  84. RahatiS. ShahrakiM. ArjomandG. ShahrakiT. Food pattern, lifestyle and diabetes mellitus.Int. J. High Risk Behav. Addict.201431e872510.5812/ijhrba.872524971303
     [Google Scholar]
  85. WayK.L. HackettD.A. BakerM.K. JohnsonN.A. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: A systematic review and meta-analysis.Diabetes Metab. J.201640425327110.4093/dmj.2016.40.4.25327535644
     [Google Scholar]
  86. FranzM.J. BantleJ.P. BeebeC.A. BrunzellJ.D. ChiassonJ.L. GargA. HolzmeisterL.A. HoogwerfB. Mayer-DavisE. MooradianA.D. PurnellJ.Q. WheelerM. Nutrition principles and recommendations in diabetes.Diabetes Care200427Suppl. 1s3610.2337/diacare.27.2007.S3614693924
     [Google Scholar]
  87. YazdanpanahL. NasiriM. AdarvishiS. Literature review on the management of diabetic foot ulcer.World J. Diabetes201561375310.4239/wjd.v6.i1.3725685277
     [Google Scholar]
  88. KolliasA.N. UlbigM.W. Diabetic retinopathy: Early diagnosis and effective treatment.Dtsch. Arztebl. Int.20101075758320186318
     [Google Scholar]
  89. EliassonB. Cigarette smoking and diabetes.Prog. Cardiovasc. Dis.200345540541310.1016/S0033‑0620(03)80004‑X12704597
     [Google Scholar]
  90. AdamS. AzmiS. HoJ.H. LiuY. FerdousiM. SiahmansurT. KaltenieceA. MarshallA. DhageS.S. IqbalZ. D’SouzaY. NathaS. KalraP.A. DonnR. AmmoriB.J. SyedA.A. DurringtonP.N. MalikR.A. SoranH. Improvements in diabetic neuropathy and nephropathy after bariatric surgery: A prospective cohort study.Obes. Surg.202131255456310.1007/s11695‑020‑05052‑833104989
     [Google Scholar]
  91. MilenkovicT. BozhinovskaN. MacutD. Bjekic-MacutJ. RahelicD. Velija AsimiZ. BurekovicA. Mediterranean diet and type 2 diabetes mellitus: A perpetual inspiration for the scientific world. A review.Nutrients2021134130710.3390/nu1304130733920947
     [Google Scholar]
  92. CallejasD. MannC.J. AyusoE. LageR. GrifollI. RocaC. AndaluzA. Ruiz-de GopeguiR. MontanéJ. MuñozS. FerreT. HaurigotV. ZhouS. RuberteJ. MingozziF. HighK.A. GarciaF. BoschF. Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy.Diabetes20136251718172910.2337/db12‑111323378612
     [Google Scholar]
  93. PraidouA. AndroudiS. BrazitikosP. KarakiulakisG. PapakonstantinouE. DimitrakosS. Angiogenic growth factors and their inhibitors in diabetic retinopathy.Curr. Diabetes Rev.20106530431210.2174/15733991079336081520594164
     [Google Scholar]
  94. SangoiM.B. de CarvalhoJ.A.M. TatschE. HausenB.S. BollickY.S. LonderoS.W.K. DuarteT. ScolariR. DuarteM.M.M.F. PremaorM.O. ComimF.V. MorettoM.B. MorescoR.N. Urinary inflammatory cytokines as indicators of kidney damage in type 2 diabetic patients.Clin. Chim. Acta201646017818310.1016/j.cca.2016.06.02827353644
     [Google Scholar]
  95. ThakurV. GonzalezM. PenningtonK. ChattopadhyayM. Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals.Mol. Cell. Neurosci.201672465310.1016/j.mcn.2016.01.00626802537
     [Google Scholar]
  96. AlokeC. EgwuC.O. AjaP.M. ObasiN.A. ChukwuJ. AkumaduB.O. OgbuP.N. AchilonuI. Current advances in the management of diabetes mellitus.Biomedicines20221010243610.3390/biomedicines1010243636289697
     [Google Scholar]
  97. ChellappanD.K. SivamN.S. TeohK.X. LeongW.P. FuiT.Z. ChooiK. KhooN. YiF.J. ChellianJ. ChengL.L. DahiyaR. GuptaG. SinghviG. NammiS. HansbroP.M. DuaK. Gene therapy and type 1 diabetes mellitus.Biomed. Pharmacother.20181081188120010.1016/j.biopha.2018.09.13830372820
     [Google Scholar]
  98. Prud’hommeG.J. Draghia-AkliR. WangQ. Plasmid-based gene therapy of diabetes mellitus.Gene Ther.200714755356410.1038/sj.gt.330290717215847
     [Google Scholar]
  99. PäthG. PerakakisN. MantzorosC.S. SeufertJ. Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells.Metabolism20199011510.1016/j.metabol.2018.10.00530342065
     [Google Scholar]
  100. PanditR. PhadkeA. JagtapA. Antidiabetic effect of Ficus religiosa extract in streptozotocin-induced diabetic rats.J. Ethnopharmacol.2010128246246610.1016/j.jep.2010.01.02520080167
     [Google Scholar]
  101. AkpanE.J. OkokonJ.E. OffongE. Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Melanthera scandens.Asian Pac. J. Trop. Biomed.20122752352710.1016/S2221‑1691(12)60089‑623569963
     [Google Scholar]
  102. CaoY. Mesenchymal stem cells improve healing of diabetic foot ulcer.J Diabetes Res.20172017932834710.1155/2017/9328347
     [Google Scholar]
  103. KharbikarB.N. MohindraP. DesaiT.A. Biomaterials to enhance stem cell transplantation.Cell Stem Cell202229569272110.1016/j.stem.2022.04.00235483364
     [Google Scholar]
  104. BlackL. ZorinaT. Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus.Drug Discov. Today202025238039110.1016/j.drudis.2019.11.01631837998
     [Google Scholar]
  105. ThotaR.N. AcharyaS.H. AbbottK.A. GargM.L. Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): Study protocol for a randomised controlled trial.Trials201617156510.1186/s13063‑016‑1702‑927894336
     [Google Scholar]
  106. YuanY. KoliosA.G.A. LiuY. ZhangB. LiH. TsokosG.C. ZhangX. Therapeutic potential of interleukin-2 in autoimmune diseases.Trends Mol. Med.202228759661210.1016/j.molmed.2022.04.01035624009
     [Google Scholar]
  107. WuY. ZhangC. GuoR. WuD. ShiJ. LiL. ChuY. YuanX. GaoJ. Mesenchymal stem cells: An overview of their potential in cell-based therapy for diabetic nephropathy.Stem Cells Int.2021202111210.1155/2021/662081133815509
     [Google Scholar]
  108. ShehadehM.B. SuaifanG.A.R.Y. Abu-OdehA.M. Plants secondary metabolites as blood glucose-lowering molecules.Molecules20212614433310.3390/molecules2614433334299610
     [Google Scholar]
  109. ZulkurnainE.I. RamliS. AliA.A. JamesR.J. KamarazamanI.S. HalimH. The phytochemical and pharmacological effects of hibiscus rosa-sinensis: A review.Int. J. Pharm. Investig.202313342243110.5530/ijpi.13.3.053
     [Google Scholar]
  110. SwatiK. BhattV. SendriN. BhattP. BhandariP. Swertia chirayita: A comprehensive review on traditional uses, phytochemistry, quality assessment and pharmacology.J. Ethnopharmacol.202330011571410.1016/j.jep.2022.11571436113678
     [Google Scholar]
  111. NaikJ. DavidM. Phytofabrication of silver and zinc oxide nanoparticles using the fruit extract of Phyllanthus emblica and its potential anti-diabetic and anti-cancer activity.Particul. Sci. Technol.202341676177310.1080/02726351.2022.2141668
     [Google Scholar]
  112. Sonawane AP. PatelA. GhawateV. Albizia odoratissima: Review on morphology, therapeutic uses, phytochemical study and pharmacological activities.Res. J. Pharmacognosy Phytother.202315322522910.52711/0975‑4385.2023.00035
     [Google Scholar]
  113. EnechiO.C. Evaluation of the anti-inflammatory and antioxidant properties of flavonoid-rich seed extract of Buchholzia coriacea Engler (Capparaceae).Trop. J. Nat. Prod. Res.202261017271732
     [Google Scholar]
  114. BhattacharyaS. SalamaH.H.A-E.A. Natural Food Preservatives.CRC Press202310.1201/9781003367765
     [Google Scholar]
  115. ArunachalamK. ParimelazhaganT. Antidiabetic activity of Ficus amplissima Smith. bark extract in streptozotocin induced diabetic rats.J. Ethnopharmacol.2013147230231010.1016/j.jep.2013.03.00423506985
     [Google Scholar]
  116. MuniyandiK. JagadeesanG. GeorgeB.P. ManoharanA.L. NatarajG. AbrahamseH. ThangarajP. α-Glucosidase, α-amylase inhibition kinetics, in vitro gastro-intestinal digestion, and apoptosis inducing abilities of Ficus microcarpa L. f. and Ficus racemosa L. fruit polysaccharides.Food Sci. Biotechnol.202231131717172810.1007/s10068‑022‑01162‑436312993
     [Google Scholar]
  117. Muñiz-RamirezA. Antidiabetic activity of Aloe vera leaves.Evid Based Complement Alternat Med. 20202020637120110.1155/2020/6371201
     [Google Scholar]
  118. Kahksha AlamO. NaazS. SharmaV. ManaithiyaA. KhanJ. AlamA. Recent developments made in the assessment of the antidiabetic potential of gymnema species - From 2016 to 2020.J. Ethnopharmacol.202228611490810.1016/j.jep.2021.11490834906636
     [Google Scholar]
  119. InsanuM. Chemical compounds and pharmacological activities of Cucumis genus.Biointerface Res. Appl. Chem.202212113241334
     [Google Scholar]
  120. NarayanankuttyA. JobJ.T. Moothakoottil KuttithodiA. SasidharanA. BenilP.B. RameshV. Farouk ElsadekM. RizwanaH. Essam El-DinM.M. Proximate composition, antioxidant, anti-inflammatory and anti-diabetic properties of the haustorium from Coconut (Cocos nucifera L.) and Palmyra palm (Borassus flabellifer L.).J. King Saud Univ. Sci.202335110240410.1016/j.jksus.2022.102404
     [Google Scholar]
  121. PavlovićM.O. StajićM. GašićU. Duletić-LauševićS. ĆilerdžićJ. The chemical profiling and assessment of antioxidative, antidiabetic and antineurodegenerative potential of Kombucha fermented Camellia sinensis, Coffea arabica and Ganoderma lucidum extracts.Food Funct.202314126227610.1039/D2FO02979K36484426
     [Google Scholar]
  122. HaoZ. ZhangY. CaoY. SunY. WangY. ZhangC. LiangD. LiuY. FengW. Chemical constituents from Acorus calamus with potent anti-diabetic and hepatoprotective activities.Fitoterapia202316910559110.1016/j.fitote.2023.10559137343685
     [Google Scholar]
  123. SaranyaR. ThirumalaiT. HemalathaM. BalajiR. DavidE. Pharmacognosy of Enicostemma littorale: A review.Asian Pac. J. Trop. Biomed.201331798410.1016/S2221‑1691(13)60028‑323570022
     [Google Scholar]
  124. JaiswalN. BhatiaV. SrivastavaS.P. SrivastavaA.K. TamrakarA.K. Antidiabetic effect of Eclipta alba associated with the inhibition of alpha-glucosidase and aldose reductase.Nat. Prod. Res.201226242363236710.1080/14786419.2012.66264822348789
     [Google Scholar]
  125. MolligodaS.P. Pharmacological activities of Eclipta alba (L.) Hassk.(Bhringaraja): A review.GSCARR20231528597
     [Google Scholar]
  126. YoshinoK. MiyauchiY. KanetakaT. TakagiY. KogaK. Anti-diabetic activity of a leaf extract prepared from Salacia reticulata in mice.Biosci. Biotechnol. Biochem.20097351096110410.1271/bbb.8085419420711
     [Google Scholar]
  127. WasanaK.G.P. AttanayakeA.P. ArawwawalaL.D.A.M. Ethnobotanical survey on medicinal plants used for the treatment of diabetes mellitus by Ayurveda and traditional medicine practitioners in Galle district of Sri Lanka.Eur. J. Integr. Med.20225510217710.1016/j.eujim.2022.102177
     [Google Scholar]
  128. AtchibriA. Screening for antidiabetic activity and phytochemical constituents of common bean (Phaseolus vulgaris L.) seeds.J. Med. Plants Res.201041717571761
     [Google Scholar]
  129. SanchetiS. SanchetiS. SeoS.Y. Antidiabetic and antiacetylcholinesterase effects of ethyl acetate fraction of Chaenomeles sinensis (Thouin) Koehne fruits in streptozotocin-induced diabetic rats.Exp. Toxicol. Pathol.2013651-2556010.1016/j.etp.2011.05.01021764274
     [Google Scholar]
  130. OrhanN. AslanM. ŞüküroğluM. Deliorman OrhanD. In vivo and in vitro antidiabetic effect of Cistus laurifolius L. and detection of major phenolic compounds by UPLC–TOF-MS analysis.J. Ethnopharmacol.2013146385986510.1016/j.jep.2013.02.01623462413
     [Google Scholar]
  131. KambaleE.K. Quetin-LeclercqJ. MemvangaP.B. BeloquiA. An overview of herbal-based antidiabetic drug delivery systems: Focus on lipid- and inorganic-based nanoformulations.Pharmaceutics20221410213510.3390/pharmaceutics1410213536297570
     [Google Scholar]
  132. YedelliK. PathangiR.K. Antidiabetic activity of medicinal plants: An updated overview of streptozotocin and alloxan-induced diabetic models.TJNPR2022671047
     [Google Scholar]
  133. DayalR. Possible therapeutic potential of Helicteres isora (L.) and it’s mechanism of action in diseases.J. Med. Plants Stud.20153295100
     [Google Scholar]
  134. da SilvaA.K.A. dos SantosC.R. CarneiroM.L.B. JoanittiG.A. LuzG.V.S. RosaS.S.R.F. PinheiroW.M. RosaM.F.F. AbreuP.R.A. FukuokaF.M.G. Tatmatsu-RochaJ.C. Bixa orellana L. and its implications in human health: Perspectives and new trends.Stud. Nat. Prod. Chem.20237713610.1016/B978‑0‑323‑91294‑5.00001‑4
     [Google Scholar]
  135. PatilS.M. ShirahattiP.S. RamuR. Azadirachta indica A. Juss ( neem ) against diabetes mellitus: a critical review on its phytochemistry, pharmacology, and toxicology.J. Pharm. Pharmacol.202274568171010.1093/jpp/rgab09834562010
     [Google Scholar]
  136. AshrafA. IjazM.U. MuzammilS. NazirM.M. ZafarS. ZihadS.M.N.K. UddinS.J. HasnainM.S. NayakA.K. The role of bixin as antioxidant, anti-inflammatory, anticancer, and skin protecting natural product extracted from Bixa orellana L.Fitoterapia202316910561210.1016/j.fitote.2023.10561237454777
     [Google Scholar]
  137. IshaqA.R. El-NasharH.A.S. YounisT. MangatM.A. ShahzadiM. Ul HaqA.S. El-ShazlyM. Genus Lupinus ( Fabaceae ): A review of ethnobotanical, phytochemical and biological studies.J. Pharm. Pharmacol.202274121700171710.1093/jpp/rgac05836039938
     [Google Scholar]
  138. GonçalvesA. Flores-FélixJ. CoutinhoP. AlvesG. SilvaL. Zimbro (Juniperus communis L.) as a promising source of bioactive compounds and biomedical activities: A review on recent trends.Int. J. Mol. Sci.2022236319710.3390/ijms2306319735328621
     [Google Scholar]
  139. MandalS.K. RathS.K. LogeshR. MishraS.K. DevkotaH.P. DasN. Capsicum annuum L. and its bioactive constituents: A critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issues.Phytother. Res.2023373965100210.1002/ptr.766036255140
     [Google Scholar]
  140. AhmadZ. ShahzadA. EmamverdianA. RamakrishnanM. DingY. Genus decalepis: Biology, importance and biotechnological interventions.Agronomy202212485510.3390/agronomy12040855
     [Google Scholar]
  141. MouryaP. A review of herbal drugs and prospective studies for management of diabetes mellitus.Int. J. Adv. Sci. Res.202314032028
     [Google Scholar]
  142. MajeedM. NarayananN.K. MundkurL. PrakasanP. NagabhushanamK. Super fruit amla (Emblica officinalis, Gaertn) in diabetes management and ensuing complications: A concise review.Nutraceuticals20233332935210.3390/nutraceuticals3030026
     [Google Scholar]
  143. JafariF. RamezaniM. NomaniH. AmiriM.S. MoghadamA.T. SahebkarA. EmamiS.A. MohammadpourA.H. Therapeutic effect, chemical composition, ethnobotanical profile of Eucalyptus globulus: A review.Lett. Org. Chem.202118641945210.2174/1570178617999200807213043
     [Google Scholar]
  144. FattepurS. Kumar SahuR. Singh JangdeyM. SreeharshaN. Chanabasappa NilugalK. AbdullahI. SharmaU. BiswalJ. Rani BhuyanJ. Systematic review on phytochemistry and pharmacology studies of Alangium salvifolium.Res J Pharm Technol20221562831283710.52711/0974‑360X.2022.00473
     [Google Scholar]
  145. OsafoN. MensahK.B. YeboahO.K. Phytochemical and pharmacological review of Cryptolepis sanguinolenta (Lindl.) Schlechter.Adv Pharmacol Sci.201720173026370
     [Google Scholar]
  146. CannellR.J. KellamS.J. OwsiankaA.M. WalkerJ.M. Microalgae and cyanobacteria as a source of glycosidase inhibitors.J. Gen. Microbiol.19871337170117053117966
     [Google Scholar]
  147. SunZ. LiuJ. ZengX. HuangfuJ. JiangY. WangM. ChenF. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.Food Funct.20112525125810.1039/c1fo10021a21779563
     [Google Scholar]
  148. MayerA.M.S. PierceM.L. HoweK. RodríguezA.D. Taglialatela-ScafatiO. NakamuraF. FusetaniN. Marine pharmacology in 2018: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; Affecting the immune and nervous systems, and other miscellaneous mechanisms of action.Pharmacol. Res.202218310639110.1016/j.phrs.2022.10639135944805
     [Google Scholar]
  149. ParkS.R. KimJ.H. JangH.D. YangS.Y. KimY.H. Inhibitory activity of minor phlorotannins from Ecklonia cava on α-glucosidase.Food Chem.201825712813410.1016/j.foodchem.2018.03.01329622188
     [Google Scholar]
  150. Moldes-AnayaA. SætherT. UhligS. NebbH. LarsenT. EilertsenH. PaulsenS. Two isomeric C16 oxo-fatty acids from the diatom chaetoceros karianus show dual agonist activity towards human peroxisome proliferator-activated receptors (PPARs) α/γ.Mar. Drugs201715614810.3390/md1506014828587091
     [Google Scholar]
  151. ChuM.J. TangX.L. HanX. LiT. LuoX.C. JiangM.M. van OfwegenL. LuoL.Z. ZhangG. LiP.L. LiG.Q. Metabolites from the paracel islands soft coral Sinularia cf. molesta.Mar. Drugs2018161251710.3390/md1612051730572615
     [Google Scholar]
  152. RoxasJ.D.P. San JuanM.A.D. VillagraciaA.R.C. EspirituR.A. An in silico analysis of the interaction of marine sponge-derived bioactive compounds with type 2 diabetes mellitus targets DPP-4 and PTP1B.J. Biomol. Struct. Dyn.202411410.1080/07391102.2024.230175138189304
     [Google Scholar]
  153. SivaramakrishnanR. In vitro anti-diabetic and anti-inflammatory activities of metabolites isolated from Marine Sponge, Heteronema erecta (Keller, 1889) and its in silico studies.Res. J. Biotechnol. Vol20201512
     [Google Scholar]
  154. GoyalM.R. SuleriaH.A.R. KirubanandanS. Technological processes for marine foods, from water to fork: Bioactive compounds, industrial applications, and genomics.CRC Press201910.1201/9780429425271
     [Google Scholar]
  155. HauberA.B. MohamedA.F. JohnsonF.R. FalveyH. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents.Diabet. Med.200926441642410.1111/j.1464‑5491.2009.02696.x19388973
     [Google Scholar]
  156. BowlingF.L. RashidS.T. BoultonA.J.M. Preventing and treating foot complications associated with diabetes mellitus.Nat. Rev. Endocrinol.2015111060661610.1038/nrendo.2015.13026284447
     [Google Scholar]
  157. VlassaraH. FuhH. MakitaZ. KrungkraiS. CeramiA. BucalaR. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications.Proc. Natl. Acad. Sci. USA19928924120431204710.1073/pnas.89.24.120431465438
     [Google Scholar]
  158. BadawiA. KlipA. HaddadP. ColeD.E. BailoB.G. El-SohemyA. KarmaliM. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.Diabetes Metab. Syndr. Obes.2010317318610.2147/DMSO.S908921437087
     [Google Scholar]
  159. ZhangY. LuoJ. ZhangQ. DengT. Growth factors, as biological macromolecules in bioactivity enhancing of electrospun wound dressings for diabetic wound healing: A review.Int. J. Biol. Macromol.2021193Pt A20521810.1016/j.ijbiomac.2021.09.21034627847
     [Google Scholar]
  160. ChungW.K. ErionK. FlorezJ.C. HattersleyA.T. HivertM.F. LeeC.G. McCarthyM.I. NolanJ.J. NorrisJ.M. PearsonE.R. PhilipsonL. McElvaineA.T. CefaluW.T. RichS.S. FranksP.W. Precision medicine in diabetes: A consensus report from the american diabetes association (ADA) and the european association for the study of diabetes (EASD).Diabetes Care20204371617163510.2337/dci20‑002232561617
     [Google Scholar]
  161. AdkiK.M. KulkarniY.A. Potential biomarkers in diabetic retinopathy.Curr. Diabetes Rev.202016997198310.2174/18756417MTA0uNTMf532065092
     [Google Scholar]
  162. FlegJ.L. EvansG.W. MargolisK.L. BarzilayJ. BasileJ.N. BiggerJ.T. CutlerJ.A. GrimmR. PedleyC. PetersonK. Pop-BusuiR. Sperl-HillenJ. CushmanW.C. Orthostatic hypotension in the ACCORD (action to control cardiovascular risk in diabetes) blood pressure trial: Prevalence, incidence, and prognostic significance.Hypertension201668488889510.1161/HYPERTENSIONAHA.116.0747427504006
     [Google Scholar]
  163. van SteenS.C. WoodwardM. ChalmersJ. LiQ. MarreM. CooperM.E. HametP. ManciaG. ColagiuriS. WilliamsB. GrobbeeD.E. DeVriesJ.H. Haemoglobin glycation index and risk for diabetes-related complications in the action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial.Diabetologia201861478078910.1007/s00125‑017‑4539‑129308539
     [Google Scholar]
  164. YewS.Q. ChiaY.C. TheodorakisM. Assessing 10-Year cardiovascular disease risk in malaysians with type 2 diabetes mellitus: Framingham cardiovascular versus United Kingdom prospective diabetes study equations.Asia Pac. J. Public Health201931762263210.1177/101053951987348731535566
     [Google Scholar]
  165. WeberM.A. JamersonK. BakrisG.L. WeirM.R. ZappeD. ZhangY. DahlofB. VelazquezE.J. PittB. Effects of body size and hypertension treatments on cardiovascular event rates: Subanalysis of the ACCOMPLISH randomised controlled trial.Lancet2013381986653754510.1016/S0140‑6736(12)61343‑923219284
     [Google Scholar]
  166. SénatM.V. AffresH. LetourneauA. Coustols-ValatM. CazaubielM. LegardeurH. JacquierJ.F. BourcigauxN. SimonE. RodA. HéronI. CasteraV. SentilhesL. BretelleF. RollandC. MorinM. DeruelleP. De CarneC. MaillotF. BeucherG. VerspyckE. DesbriereR. LaboureauS. MitanchezD. BouyerJ. Effect of glyburide vs. subcutaneous insulin on perinatal complications among women with gestational diabetes: A randomized clinical trial.JAMA2018319171773178010.1001/jama.2018.407229715355
     [Google Scholar]
  167. MaturiR.K. GlassmanA.R. JosicK. AntoszykA.N. BlodiB.A. JampolL.M. MarcusD.M. MartinD.F. MeliaM. Salehi-HadH. StockdaleC.R. PunjabiO.S. SunJ.K. Effect of intravitreous anti–vascular endothelial growth factor vs. sham treatment for prevention of vision-threatening complications of diabetic retinopathy: The protocol w randomized clinical trial.JAMA Ophthalmol.2021139770171210.1001/jamaophthalmol.2021.060633784735
     [Google Scholar]
  168. OmidianM. MahmoudiM. JavanbakhtM.H. EshraghianM.R. AbshiriniM. DaneshzadE. HasaniH. AlvandiE. DjalaliM. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.Diabetes Metab. Syndr.20191352873287710.1016/j.dsx.2019.07.04731425951
     [Google Scholar]
  169. SkylerJ.S. Effects of glycemic control on diabetes complications and on the prevention of diabetes.Clin. Diabetes200422416216610.2337/diaclin.22.4.162
     [Google Scholar]
  170. WillardA.L. HermanI.M. Vascular complications and diabetes: current therapies and future challenges. J Ophthalmol.2012201220953810.1155/2012/209538
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998291870240408043837
Loading
Therapeutic Interventions for Diabetes Mellitus-associated Complications
Curr. Diabetes Rev. 21, e030524229631 (2025); https://doi.org/10.2174/0115733998291870240408043837
/content/journals/cdr/10.2174/0115733998291870240408043837
/content/journals/cdr/10.2174/0115733998291870240408043837
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Diabetes mellitus; herbal therapy; neuropathy; pathogenesis; retinopathy; therapeutic interventions

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test